Pharmafile Logo

News and Press Releases

Attend Europe’s leading vaccine event!

World Vaccine Congress Europe will host 2500+ attendees, 280 speakers, 150 exhibitors and start-ups over the course of 4 days. With a multitude of tracks, the congress will cover everything...

Category: Biotechnology, Other, Pharmaceutical
Posted: May 27, 2025

World Vaccine Congress Europe
tayyab.abbasi@terrapinn.com
Barcelona

Big names, big issues: Chemspec Europe 2025 to deliver strong insights and momentum at a pivotal time for the chemicals industry

22 May 2025 -- Koelnmesse, Germany -- From 4–5 June, the international fine and speciality chemicals industry will gather at Koelnmesse, Germany, for the 38th edition of Chemspec Europe –...

Category: Biotechnology, Other, Pharmaceutical
Posted: May 22, 2025

Chemspec Europe
Koelnmesse, Germany

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

12 May 2025 -- Leiden, the Netherlands and Massachusetts, US -- ProQR Therapeutics NV (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: May 15, 2025

ProQR Therapeutics
info@proqr.com
Zernikedreef 9 2333 CK Leiden The Netherlands

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF)  Regulatory and strategic...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 1, 2025

PureTech Health
info@puretechhealth.com
PureTech Health 6 Tide Street Boston, MA 02210

FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain

1 May 2025 -- London, UK and New York, US -- OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod (formerly called OK-101) to treat NCP, an ocular...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 1, 2025

OKYO Pharma
info@okyopharma.com
OKYO Pharma Floor 4, 14/15 Conduit St London W1S 2XJ

Iksuda to present growing ADC pipeline at AACR

Introduces the ProAlk payload series to address the growing challenge of ADC sequencing IKS04 to enter clinical development for gastrointestinal cancers by end of 2025 PermaLink offers stable and scalable...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 25, 2025

Iksuda
The Biosphere, Draymans Way, Newcastle Helix Newcastle upon Tyne NE4 5BX

PLL Therapeutics enrolls first patient in phase I/II trial of drug candidate PLL001 for Amyotrophic Lateral Sclerosis (ALS)

Multi-stage Australian study will evaluate safety of PLL001 in 12 ALS patients, testing three different doses along with placebo 140 ALS patients will participate in second stage of study to...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 15, 2025

PLL Therapeutics
contact@pll-therapeutics.com
10 Avenue Roger Lapébie 33140 Villenave d’Ornon France

ChinaBio Partnering Forum 2025: Connecting China’s Biotech Innovations with the Global Life Science Ecosystem

1 April 2025 -- Shanghai, China -- ChinaBio® Partnering Forum, the largest and most productive life science partnering event in China, returns in 2025 with a hybrid format to facilitate...

Category: Biotechnology, Other, Pharmaceutical
Posted: April 1, 2025

ChinaBio Partnering Forum 2025
EBDCustomerService@ebdgroup.com
Kerry Hotel Pudong, Shanghai No. 1388, Hua mu Road, Pudong, Shanghai, 201204 China

OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod

Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term Stability Urcosimod stable in single-use ampoules for more than 2½ years FDA requires drug to show...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 31, 2025

OKYO Pharma
info@okyopharma.com
OKYO Pharma Floor 4, 14/15 Conduit St London W1S 2XJ

Industry Leaders Address Future of Oncology Drugs and Biotech Funding at AAPS National Biotechnology Conference

Registration Now Open 26 March 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 National Biotechnology Conference (NBC), taking place...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2025

American Association of Pharmaceutical Scientists (AAPS)
aaps@aaps.org
2107 Wilson Blvd #200 Arlington, VA 22201

ELRIG Announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025

Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May 25 March 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation for the drug...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 25, 2025

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

19 March 2025 -- Dublin, Ireland & New Jersey, US -- Amarin Corporation plc today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be presented at the American...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 24, 2025

Amarin Corp
amarinconnect@amarincorp.com
88 Harcourt Street, Dublin 2, Ireland

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front....

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 20, 2025

Sanofi
One Onslow Street, Guildford, Surrey, GU1 4YS, UK

MedExecWomen Hosts 6th Annual Conference to Discuss Future of Medtech Industry

18 March 2025 -- Massachusetts, US -- MedExecWomen, a non-profit organization focused on empowering executive women in medtech to accelerate the positive impact of medical devices, diagnostics, drug delivery, and...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: March 18, 2025

MedExecWomen
pr@scorrmarketing.com

Cherwell supports microbiological environmental monitoring best practices conference

Cleanroom microbiology experts on hand at Pharmig’s specialist conference to discuss assessment of sterility in pharmaceutical manufacturing facilities 6 March 2025 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert,...

Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: March 6, 2025

Cherwell Laboratories
sales@cherwell-labs.co.uk
Launton Business Centre Murdock Rd, Bicester OX26 4XB